Seattle Genetics Rallies To Record High On Positive Results From Midstage Breast Cancer StudyBenzinga • 10/21/19
Seattle Genetics Impresses At ESMO With Early Stage Study For Bladder Cancer PatientsSeeking Alpha • 10/09/19
Why This Biotech Stock Just Broke Out In Bullish Volume — And Another ToppledInvestors Business Daily • 09/30/19
Oppenheimer Turns Bullish On Seattle Genetics, Says Optimism Fueled By Pipeline ReadoutsBenzinga • 09/12/19
Seattle Genetics Inc (SGEN) President and CEO Clay B Siegall Sold $2.1 million of SharesGuruFocus • 08/30/19
Why Is Seattle Genetics (SGEN) Up 2.4% Since Last Earnings Report?Zacks Investment Research • 08/15/19
Seattle Genetics Inc (SGEN) President and CEO Clay B Siegall Sold $1.5 million of SharesGuruFocus • 08/09/19
Seattle Genetics, Inc. (SGEN) CEO Clay Siegall on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/17/19